Status:
COMPLETED
Peak Expiratory Flow Rate for Emergency Department Management of Acute Asthma Exacerbation
Lead Sponsor:
Hennepin Healthcare Research Institute
Conditions:
Asthma
Eligibility:
All Genders
16-55 years
Phase:
NA
Brief Summary
Patients presenting to the emergency department with acute asthma exacerbation will be assigned to peak-expiratory flow rate (PEFR) guided management and non-PEFR guided management.
Detailed Description
It is common practice to use peak-expiratory flow rate (PEFR) as an indicator of severity in patients that present with acute asthma exacerbation. There is, however, little data supporting this practi...
Eligibility Criteria
Inclusion
- Presumed diagnosis of asthma, requiring at least 2 nebulized albuterol treatments
- Presenting with acute asthma exacerbation defined as acute or subacute episodes of progressively worsening shortness of breath, cough, wheezing, and chest tightness, or some combination of these symptoms
- Start of enrollment process must occur within 15 minutes of being roomed in the ED
- Working phone number and willingness to be contacted at least 72 hours following encounter
Exclusion
- Prisoner or in custody
- Pregnant
- Known diagnosis of COPD
- Co-morbid medical conditions that patient is seeking treatment for concurrently
- Non-English speaking
- Unable to provide informed consent
- In the resuscitation bay or on non-invasive positive pressure ventilation (NPPV)
Key Trial Info
Start Date :
January 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
188 Patients enrolled
Trial Details
Trial ID
NCT03420651
Start Date
January 19 2018
End Date
November 30 2022
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55415